Immunogenicity and Protective Efficacy against Murine Tuberculosis of a Prime-Boost Regimen with BCG and a DNA Vaccine Expressing ESAT-6 and Ag85A Fusion Protein

Heterologous prime-boost regimens utilizing BCG as a prime vaccine probably represent the best hope for the development of novel tuberculosis (TB) vaccines. In this study, we examined the immunogenicity and protective efficacy of DNA vaccine (pcD685A) expressing the fusion protein of Ag85A and ESAT-...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lu, Jia, Wang, Chun, Zhou, Zhiguang, Zhang, Ying, Cao, Tingting, Shi, Chunwei, Chen, Zhenhua, Chen, Lingxia, Cai, Changxue, Fan, Xionglin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2011
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065234/
https://ncbi.nlm.nih.gov/pubmed/21461375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/617892
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia